Russell (Rusty) Katz, MD
SENIOR REGULATORY ADVISOR
Clintrex
I have 40+ years of regulatory expertise having been the Director of the FDA Division of Neurological products until my retirement in 2013. My specialty, since joining Clintrex, is helping pharma and biotech companies solve complex regulatory issues, whether it is developing the initial regulatory strategy, to helping companies come off of partial or full clinical hold, plan for pIND, IND, EOP2, pNDA or NDA meetings.